Table 5.
Group | Blood glucose level (mg/dL) | ||||
---|---|---|---|---|---|
0 hour | 2 hours | 4 hours | 6 hours | 8 hours | |
DW10 | 342.83 ± 6.98 | 356.67 ± 7.96 | 334.67 ± 11.65 | 330.33 ± 9.89 | 324.83 ± 7.67n3 |
GLC5 | 338.33 ± 12.06 | 283.33 ± 11.14β2,n3 | 216.33 ± 9.67β3,n3 | 172.17 ± 8.99 β3,n3 | 160.33 ± 5.17β3,n3 |
BAC100 | 328.67 ± 20.05 | 309.00 ± 17.87 | 284.67 ± 18.67 | 244.83 ± 19.55n3 | 219.00 ± 10.67β2,n3 |
BAC200 | 329.67 ± 17.31 | 316.17 ± 17.35 | 293.83 ± 15.08 | 233.83 ± 17.54β3,n3 | 208.50 ± 6.44β3,n3 |
BAC400 | 352.67 ± 11.62 | 325.67 ± 10.78 | 260.33 ± 17.67β3,n3 | 214.67 ± 12.36β3,n3 | 182.00 ± 11.35β3,n3 |
CFF100 | 347.50 ± 8.81 | 352.00 ± 8.45 | 341.67 ± 10.58 | 333.67 ± 11.26 | 321.00 ± 13.05 |
CFF200 | 334.00 ± 6.77 | 326.83 ± 9.09 | 314.67 ± 14.67 | 294.33 ± 11.04β1 | 268.33 ± 8.58β3 |
CFF400 | 355.83 ± 6.52 | 335.83 ± 6.77 | 320.17 ± 16.32β1 | 290.00 ± 8.27β3 | 264.33 ± 9.79β3,n1 |
EAF100 | 350.67 ± 7.92 | 340.00 ± 7.79 | 322.00 ± 12.37 | 305.00 ± 9.52β1 | 273.17 ± 13.40β3 |
EAF200 | 365.50 ± 5.58 | 347.17 ± 4.71 | 321.00 ± 20.24β3 | 285.83 ± 15.64β3 | 275.50 ± 7.08β3 |
EAF400 | 344.67 ± 9.88 | 318.00 ± 9.27 | 291.17 ± 19.35β3 | 241.50 ± 13.68β3,n3 | 230.00 ± 14.43β3,n3 |
AQF100 | 347.50 ± 9.02 | 332.83 ± 6.78 | 310.00 ± 11.87 | 292.50 ± 12.23β2 | 252.50 ± 11.74β3,n2 |
AQF200 | 339.50 ± 6.67 | 315.83 ± 10.23 | 286.17 ± 15.27β2 | 265.50 ± 10.07β3,n2 | 247.50 ± 9.48β3,n2 |
AQF400 | 362.33 ± 7.13 | 332.67 ± 6.85β1 | 293.83 ± 14.42β3 | 239.33 ± 17.52β3,n3 | 214.83 ± 7.98β3,n3 |
Abbreviations: BAC, Bersama abyssinica leaf crude extract; DW, distilled water; CFF, chloroform fraction; EAF, ethyl acetate fraction; AQF, aqueous fraction; GLC, glibenclamide.
* Each value represents mean ± SEM; n = 6 for each treatment. nCompared with the negative control, βcompared with baseline blood glucose level. 1 P < .05, 2 P < .01, 3 P < .001,